Clinical Trials in Wuwei, Gansu
14 recruiting
Showing 1–14 of 14 trials
Recruiting
Phase 3
A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer
HER2-positive Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.544 enrolled78 locationsNCT07043725
Recruiting
Not Applicable
High-flow Nasal Cannula Versus Conventional Oxygen During Awake Tracheal Intubation With Difficult Airways
Awake Tracheal IntubationDifficult Airway
Wenxian Li336 enrolled6 locationsNCT07384494
Recruiting
Phase 3
JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.
Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Shanghai Junshi Bioscience Co., Ltd.560 enrolled68 locationsNCT07284134
Recruiting
Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal Carcinoma
Esophageal Cancer
Xijing Hospital300 enrolled9 locationsNCT06979869
Recruiting
Phase 1Phase 2
Clinical Studies for the Treatment of Advanced Solid Tumors
Advanced Solid Tumor
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.194 enrolled32 locationsNCT06825494
Recruiting
Phase 2
A Clinical Trial Evaluating TQB2102 for Injection in Combination With Behmosubaisumab/Payamprolizumab With or Without Chemotherapy in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma
Gastroesophageal Adenocarcinoma
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.204 enrolled39 locationsNCT06767800
Recruiting
Not Applicable
Clinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer.
Pancreatic Cancer MetastaticPancreatic Cancer Non-resectable
Gansu Wuwei Tumor Hospital62 enrolled1 locationNCT06840067
Recruiting
Not Applicable
Clinical Study of Carbon Ion Radiotherapy for High-grade Glioma
High Grade GliomaCarbon Ion RadiotherayHeavy Ion Radiotherapy
Gansu Wuwei Tumor Hospital23 enrolled1 locationNCT06831773
Recruiting
Phase 1Phase 2
A Study of RC118 Plus Toripalimab / RC148 in Patients with Locally Advanced Unresectable or Metastatic Solid Tumors
Advanced Solid Tumor
RemeGen Co., Ltd.48 enrolled18 locationsNCT06038396
Recruiting
Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspepsia Symptoms
Helicobacter Pylori InfectionDyspepsia
Shanghai Jiao Tong University School of Medicine2,242 enrolled26 locationsNCT06422052
Recruiting
Phase 2
Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH)
Non Alcoholic Steatohepatitis
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.120 enrolled53 locationsNCT06569524
Recruiting
Phase 2
A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis B
Chronic Hepatitis B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.90 enrolled6 locationsNCT06566248
Recruiting
Phase 2
Perioperative Disitamab Vedotin Plus Toripalimab and XELOX in Gastric or Gastroesophageal Junction Adenocarcinoma.
Gastric CancerGastroesophageal Junction Adenocarcinoma
RemeGen Co., Ltd.90 enrolled11 locationsNCT06155383
Recruiting
Phase 1Phase 2
A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) .
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.107 enrolled25 locationsNCT05959694